Latest AlphaLISA(TM) Immunoassay Kits Reduce Customers' Time, Labor and Materials; Enhance Research Efforts for Cancer, Alzheimer's, Diabetes, HIV, Inflammation and Cardiovascular DiseaseApril 4, 2008--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, announced the release of eight new AlphaLISA(TM) immunoassay kits in conjunction with the Society for Biomolecular Sciences' (SBS) 14th Annual Conference and Exhibition. These latest innovations include research reagents and assays for investigating HIV, cancer, central nervous system disorders, cardiovascular disorders, and diabetes(a).
AlphaLISA is a line of highly sensitive "No-Wash" immunoassay reagents offering a wide dynamic range and easy automation for analysis of biomarkers and other analytes. The technology allows researchers to replace multi-step, cumbersome ELISAs with a high throughput screening (HTS) platform, significantly reducing the time, labor and materials necessary for processing complex samples... PerkinElmer's Press Release -
